Page last updated: 2024-10-30

labetalol and Exanthem

labetalol has been researched along with Exanthem in 2 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ur Rehman, H1
Ahlijah, W1
Sivagnanam, G1

Other Studies

2 other studies available for labetalol and Exanthem

ArticleYear
Rumpel Leede phenomenon.
    The journal of ECT, 2012, Volume: 28, Issue:4

    Topics: Adrenergic alpha-Antagonists; Arm; Capillaries; Depressive Disorder, Major; Diabetes Mellitus, Type

2012
Case 11-2004: a boy with rash, edema, and hypertension.
    The New England journal of medicine, 2004, Sep-09, Volume: 351, Issue:11

    Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Amoxicillin; Anti-Bacterial Agents; Child; Diagnos

2004